Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter

Details for Australian Patent Application No. 2008338059 (hide)

Owner H. Lundbeck A/S Takeda Pharmaceuticals North America, Inc.

Inventors Hefting, Nanco; Miller, Silke; Jensen, Eva Elstrup; Chon, Jin; Batra, Aneil

Agent Watermark

Pub. Number AU-A-2008338059

PCT Pub. Number WO2009/076962

Priority PA 200701791 14.12.07 DK; PA 200701798 17.12.07 DK; 61/013,884 14.12.07 US

Filing date 11 December 2008

Wipo publication date 25 June 2009

International Classifications

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076962 Priority application(s): WO2009/076962

12 August 2010 Amendment Made

  The nature of the amendment is: Delete priority details under INID (31) 61/013,884

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338063-RhoC-based immunotherapy

2008338058-4-[2,3-difluoro-6-(2-fluoro-4-methyl-phe nylsulfanyl)-phenyl]-piperidine